NCT04223999View on ClinicalTrials.gov

Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery)

PHASE2RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2026

Conditions
Recurrent Glioblastoma
Interventions
PROCEDURE

Skullremodeling surgery

"Strategically placed cranial burrholes in order to improve the TTField dose focally in the tumor."

OTHER

Control

Tumor treating fields combined with best medical treatment.

Trial Locations (1)

8200

RECRUITING

Nikola Mikic, Aarhus

All Listed Sponsors
collaborator

NovoCure GmbH

INDUSTRY

collaborator

Odense University Hospital

OTHER

collaborator

Aalborg University Hospital

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

lead

Anders Rosendal Korshøj

OTHER